STAT4 polymorphism in a Chinese Han population with Vogt-Koyanagi-Harada syndrome and Behçet's disease

Human Immunology

Volumn 71, Issue 7, 2010, Pages 723-726

  Hu, Ke ^a,b,c   Yang, Peizeng ^a,b,c   Jiang, Zhengxuan ^b,c   Hou, Shengping ^a,b,c   Du, Liping ^a,b,c   Li, Fuzhen ^b,c  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Key Laboratory of Ophthalmology   (China)

^c Chongqing Eye Institute   (China)

Author keywords

Association; Beh et's disease; Polymorphism; STAT4; Vogt Koyanagi Harada syndrome

Indexed keywords

GENOMIC DNA; STAT4 PROTEIN;

ADULT; ALOPECIA; ARTHRITIS; ARTICLE; BEHCET DISEASE; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENITAL ULCER; GENOTYPE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MUTATIONAL ANALYSIS; PATHOGENESIS; POLIOMYELITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DEFECT; TINNITUS; VITILIGO; VOGT KOYANAGI SYNDROME;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BEHCET SYNDROME; CHINA; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; STAT4 TRANSCRIPTION FACTOR; UVEOMENINGOENCEPHALITIC SYNDROME; YOUNG ADULT;

EID: 77953913256     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.04.007     Document Type: Article

References (39)

1. Norose K., Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 1996, 80:1002-1008.
2. Mizuki N., Ota M., Kimura M., Ohno S., Ando H., Katsuyama Y., et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: A strong association of six GCT repetitions with Behcet disease. Proc Natl Acad Sci U S A 1997, 94:1298-1303.
3. Frassanito M.A., Dammacco R., Cafforio P., Dammacco F. Th1 polarization of the immune response in Behcet's disease: A putative pathogenetic role of interleukin-12. Arthritis Rheum 1999, 42:1967-1974.
4. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004, 202:139-156.
5. Nishikomori R., Usui T., Wu C.Y., Morinobu A., O'Shea J.J., Strober W. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J Immunol 2002, 169:4388-4398.
6. Mathur A.N., Chang H.C., Zisoulis D.G., Stritesky G.L., Yu Q., O'Malley J.T., et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007, 178:4901-4907.
7. Korn T., Oukka M., Kuchroo V., Bettelli E. Th17 cells: Effector T cells with inflammatory properties. Semin Immunol 2007, 19:362-371.
8. Frucht D.M., Aringer M., Galon J., Danning C., Brown M., Fan S., et al. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J Immunol 2000, 164:4659-4664.
9. Kobayashi S., Ikari K., Kaneko H., Kochi Y., Yamamoto K., Shimane K., et al. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum 2008, 58:1940-1946.
10. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977-986.
11. Taylor K.E., Remmers E.F., Lee A.T., Ortmann W.A., Plenge R.M., Tian C., et al. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet 2008, 4:e1000084.
12. Martinez A., Varade J., Marquez A., Cenit M.C., Espino L., Perdigones N., et al. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. Arthritis Rheum 2008, 58:2598-2602.
13. Zervou M.I., Mamoulakis D., Panierakis C., Boumpas D.T., Goulielmos G.N. STAT4: A risk factor for type 1 diabetes?. Hum Immunol 2008, 69:647-650.
14. Zervou M.I., Goulielmos G.N., Castro-Giner F., Tosca A.D., Krueger-Krasagakis S. STAT4 gene polymorphism is associated with psoriasis in the genetically homogeneous population of Crete, Greece. Hum Immunol 2009, 70:738-741.
15. Korman B.D., Alba M.I., Le J.M., Alevizos I., Smith J.A., Nikolov N.P., et al. Variant form of STAT4 is associated with primary Sjogren's syndrome. Genes Immun 2008, 9:267-270.
16. Read R.W., Holland G.N., Rao N.A., Tabbara K.F., Ohno S., Arellanes-Garcia L., et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol 2001, 131:647-652.
17. Norose K., Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 1996, 80:1078-1080.
18. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's disease. Lancet;335:1078-80.
19. Yang P., Zhang Z., Zhou H., Li B., Huang X., Gao Y., et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 2005, 30:943-948.
20. Rutzen A.R., Ortega-Larrocea G., Schwab I.R., Rao N.A. Simultaneous onset of Vogt-Koyanagi-Harada syndrome in monozygotic twins. Am J Ophthalmol 1995, 119:239-240.
21. Villanueva J.L., Gonzalez-Dominguez J., Gonzalez-Fernandez R., Prada J.L., Pena J., Solana R. Hla antigen familial study in complete Behcet's syndrome affecting three sisters. Ann Rheum Dis 1993, 52:155-157.
22. Yang P., Ren Y., Li B., Fang W., Meng Q., Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology 2007, 114:606-614.
23. Verity D.H., Marr J.E., Ohno S., Wallace G.R., Stanford M.R. Behcet's disease, the silk road and HLA-B51: Historical and geographical perspectives. Tissue Antigens 1999, 54:213-220.
24. Cohen R., Metzger S., Nahir M., Chajek-Shaul T. Association of the MIC-A gene and HLA-B51 with Behcet's disease in Arabs and non-Ashkenazi Jews in Israel. Ann Rheum Dis 2002, 61:157-160.
25. Sakly N., Boumiza R., Zrour-Hassen S., Hamzaoui A., Ben Yahia S., Amara H., et al. HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behcet's disease. Ann NY Acad Sci 2009, 1173:564-569.
26. Islam S.M., Numaga J., Matsuki K., Fujino Y., Maeda H., Masuda K. Influence of HLA-DRB1 gene variation on the clinical course of Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1994, 35:752-756.
27. Zetterquist H., Olerup O. Identification of the HLA-DRB1* 04, -DRB1* 07, and -DRB1r* 09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol 1992, 34:64-74.
28. Du L., Yang P., Hou S., Lin X., Zhou H., Huang X., et al. Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome. Clin Immunol 2008, 127:43-48.
29. Hou S., Yang P., Du L., Zhou H., Lin X., Liu X., Kijlstra A. SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease. Clin Immunol 2008, 129:170-175.
30. + T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 2007, 119:1218-1224.
31. Chi W., Zhu X., Yang P., Liu X., Lin X., Zhou H., et al. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci 2008, 49:3058-3064.
32. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., et al. Either a Th17 or a Th1 effector response can drive autoimmunity: Conditions of disease induction affect dominant effector category. J Exp Med 2008, 205:799-810.
33. Amadi-Obi A., Yu C.R., Liu X., Mahdi R.M., Clarke G.L., Nussenblatt R.B., et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007, 13:711-718.
34. Suzuki Kurokawa M., Behcet S.N. s disease. Clin Exp Med 2004, 4:10-20.
35. Deuter C.M., Kötter I., Wallace G.R., Murray P.I., Stübiger N., Zierhut M. Behcet's disease: Ocular effects and treatment. Prog Retin Eye Res 2008, 27:111-136.
36. Lee H.S., Remmers E.F., Le J.M., Kastner D.L., Bae S.C., Gregersen P.K. Association of STAT4 with rheumatoid arthritis in the Korean population. Mol Med 2007, 13:455-460.
37. Orozco G., Alizadeh B.Z., Delgado-Vega A.M., Gonzalez-Gay M.A., Balsa A., Pascual-Salcedo D., et al. Association of STAT4 with rheumatoid arthritis: A replication study in three European populations. Arthritis Rheum 2008, 58:1974-1980.
38. Yang P., Fang W., Meng Q., Ren Y., Xing L., Kijlstra A. Clinical features of Chinese patients with Behcet's disease. Ophthalmology 2008, 115:312-318.
39. Korman B.D., Kastner D.L., Gregersen P.K., Remmers E.F. STAT4: Genetics, mechanisms, and implications for autoimmunity. Curr Allergy Asthma Rep 2008, 8:398-403.